product of Boehringer

Boehringer Is Set to Launch Diabetes in India with Eli Lilly
Nov 27, 2012
Boehringer Ingelheim India and Eli Lilly India is set to launch Linagliptin (brand name trajenta) 5mg film-coated tablets, for Type 2 diabetes in adults, in India. Linagliptin, which is approved in the US, the European Union, Japan and ...

Tags: Diabetes Drug, product of Boehringer, diabetes epidemic